CURIS INC (CRIS)

↓ Download CSV

CIK 0001108205 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CURIS INC reported revenue of $9.44M, down 13.4% from the prior year. The company ran a net loss, with a net margin of -80.3%. It held $19.97M in total assets against $14.50M in total liabilities.

Key ratios (FY2025)

-60.5%
Operating margin
-80.3%
Net margin
-138.8%
Return on equity
-13.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$9.44M$10.91M$10.02M$10.16M$10.65M$10.84M$10.00M$10.43M$9.90M
Operating Income-$5.71M-$44.54M-$48.33M-$53.02M-$42.06M-$24.90M-$24.36M-$29.33M-$49.76M-$58.04M
Net Income-$7.58M-$43.39M-$47.41M-$56.67M-$45.44M-$29.91M-$32.14M-$32.58M-$53.32M-$60.41M
EPS (Diluted)$-0.58$-6.88$-8.96$-12.14$0.50$-0.61$-0.97
Total Assets$19.97M$41.27M$77.28M$108.85M$162.30M$204.36M$35.11M$37.37M$73.80M$57.75M
Total Liabilities$14.50M$47.26M$57.61M$62.30M$71.59M$73.69M$69.02M$41.86M$49.80M$28.49M
Shareholders' Equity$5.46M-$6.00M$19.67M$46.55M$90.71M$130.67M-$33.91M-$4.50M$23.99M$29.45M
Cash & Equivalents$5.06M$20.00M$26.68M$19.66M$40.01M$129.61M$15.43M$23.64M$38.29M$26.04M
Operating Cash Flow-$27.20M-$39.56M-$38.43M-$54.34M-$37.62M-$25.74M-$26.20M-$30.07M-$48.35M-$35.81M
Capital Expenditures$0$416.0K$0$677.0K$41.0K$85.0K$188.0K$329.0K
Shares Outstanding12.93M8.49M5.89M4.83M91.65M91.50M33.24M33.16M32.83M141.12M